Sanofi said it would halt development of its vaccine against Covid-19 based on mRNA technology despite it having showed positive early-stage trial results.
賽諾菲(Sanofi)表示將停止對(duì)基于mRNA技術(shù)的新冠疫苗的研發(fā)，盡管該公司已經(jīng)在早期試驗(yàn)中取得了積極成果。
您已閱讀10%（210字），剩余90%（1802字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。